CA2688486A1 - Formulations de sesquiterpene, trousses et procedes d'utilisation associes - Google Patents

Formulations de sesquiterpene, trousses et procedes d'utilisation associes Download PDF

Info

Publication number
CA2688486A1
CA2688486A1 CA002688486A CA2688486A CA2688486A1 CA 2688486 A1 CA2688486 A1 CA 2688486A1 CA 002688486 A CA002688486 A CA 002688486A CA 2688486 A CA2688486 A CA 2688486A CA 2688486 A1 CA2688486 A1 CA 2688486A1
Authority
CA
Canada
Prior art keywords
pharmaceutical composition
caryophyllene
beta
group
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002688486A
Other languages
English (en)
Inventor
Jean Legault
Andre Pichette
Serge Lavoie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FPL Pharma Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/CA2008/000865 external-priority patent/WO2008144880A1/fr
Application filed by Individual filed Critical Individual
Priority to CA002688486A priority Critical patent/CA2688486A1/fr
Publication of CA2688486A1 publication Critical patent/CA2688486A1/fr
Abandoned legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002688486A 2007-05-31 2008-06-02 Formulations de sesquiterpene, trousses et procedes d'utilisation associes Abandoned CA2688486A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002688486A CA2688486A1 (fr) 2007-05-31 2008-06-02 Formulations de sesquiterpene, trousses et procedes d'utilisation associes

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US94111707P 2007-05-31 2007-05-31
US60/941,117 2007-05-31
PCT/CA2008/000865 WO2008144880A1 (fr) 2007-05-31 2008-05-06 Compositions servant à prévenir ou à traiter le syndrome d'anorexie-cachexie et leurs procédés d'utilisation
CAPCT/CA2008/000865 2008-05-06
PCT/CA2008/001063 WO2008144942A1 (fr) 2007-05-31 2008-06-02 Formulations de sesquiterpène, trousses et procédés d'utilisation associés
CA002688486A CA2688486A1 (fr) 2007-05-31 2008-06-02 Formulations de sesquiterpene, trousses et procedes d'utilisation associes

Publications (1)

Publication Number Publication Date
CA2688486A1 true CA2688486A1 (fr) 2008-12-04

Family

ID=41571027

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002688486A Abandoned CA2688486A1 (fr) 2007-05-31 2008-06-02 Formulations de sesquiterpene, trousses et procedes d'utilisation associes

Country Status (1)

Country Link
CA (1) CA2688486A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201800004027A1 (it) * 2018-03-28 2019-09-28 Jointherapeutics S R L Composizione per il trattamento di patologie infiammatorie
CN114377067A (zh) * 2020-10-22 2022-04-22 中国科学院上海营养与健康研究所 葡萄籽提取物在制备靶向清除肿瘤微环境衰老细胞及抑制肿瘤的药物中的用途

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201800004027A1 (it) * 2018-03-28 2019-09-28 Jointherapeutics S R L Composizione per il trattamento di patologie infiammatorie
WO2019186355A1 (fr) * 2018-03-28 2019-10-03 Jointherapeutics Srl Composition pour le traitement de maladies inflammatoires
CN114377067A (zh) * 2020-10-22 2022-04-22 中国科学院上海营养与健康研究所 葡萄籽提取物在制备靶向清除肿瘤微环境衰老细胞及抑制肿瘤的药物中的用途

Similar Documents

Publication Publication Date Title
US20110008465A1 (en) Sesquiterpene formulations, kits and methods of use thereof
Shi et al. Co-delivery of docetaxel and chloroquine via PEO–PPO–PCL/TPGS micelles for overcoming multidrug resistance
Li et al. Development of targeting lonidamine liposomes that circumvent drug-resistant cancer by acting on mitochondrial signaling pathways
Nakase et al. Transferrin receptor-dependent cytotoxicity of artemisinin–transferrin conjugates on prostate cancer cells and induction of apoptosis
Wang et al. Lethal quercetin-digoxin interaction in pigs
US11963942B2 (en) Oral taxane compositions and methods
Cortes et al. Eribulin mesylate, a novel microtubule inhibitor in the treatment of breast cancer
MX2014001586A (es) Formulaciones de cabazitaxel y metodos para preparar las mismas.
WO2012031293A1 (fr) Compositions et méthodes utilisables en vue du traitement du cancer
WO2015172712A1 (fr) Composition pharmaceutique pour injection avec effet synergique de la vitamine c et des médicaments antitumoraux
US11439586B2 (en) Intratumour injection formulation
PT1189637E (pt) Composições para melhorar a biodisponibilidade de fármacos administrados oralmente
Sartaj et al. Exploring the therapeutic potential of nanostructured lipid carrier approaches to tackling the inherent lacuna of chemotherapeutics and herbal drugs against breast cancer
Ho et al. Enhanced oral bioavailability of paclitaxel by d-α-tocopheryl polyethylene glycol 400 succinate in mice
CA2688486A1 (fr) Formulations de sesquiterpene, trousses et procedes d'utilisation associes
EP2632264B1 (fr) Nouvelles formulations de composés chimiques hydro-insolubles et procédés d'utilisation d'une formulation de composé fl118 pour thérapie cancéreuse
Hao et al. Novel fluorinated docetaxel analog for anti-hepatoma: Molecular docking and biological evaluation
CN111773388A (zh) A-失碳-5α雄甾烷化合物类药物与抗癌药物的联合应用
CA2530311A1 (fr) Traitement du cancer au moyen d'epothilones
Calleja New chemotherapy approaches based on mucus-penetrating nanoparticles as carriers for paclitaxel

Legal Events

Date Code Title Description
FZDE Discontinued